206 related articles for article (PubMed ID: 35182550)
1. Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1.
Shi H; Zhang Y; Wang Y; Fang P; Liu Y; Li W
Toxicol Appl Pharmacol; 2022 Mar; 439():115926. PubMed ID: 35182550
[TBL] [Abstract][Full Text] [Related]
2. Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway.
Danni X; Jiangzheng Z; Huamao S; Yinglian P; Changcheng Y; Yanda L
Bioengineered; 2021 Dec; 12(1):7335-7347. PubMed ID: 34612768
[TBL] [Abstract][Full Text] [Related]
3. CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.
Liu Y; Zhang X; Lin J; Chen Y; Qiao Y; Guo S; Yang Y; Zhu G; Pan Q; Wang J; Sun F
Cell Death Dis; 2019 Sep; 10(9):644. PubMed ID: 31501420
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C
BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Ras protein activator like 2 produces antitumor effects in gastric cancer via the suppression of YAP1 activation.
Hu Y; Zhang P; Shi Y; Dong X; Wu Y; Dong D; Li E; Fan Y
Environ Toxicol; 2022 Mar; 37(3):527-538. PubMed ID: 34826200
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
10. Deactivation of AKT/GSK-3β-mediated Wnt/β-catenin pathway by silencing of KIF26B weakens the malignant behaviors of non-small cell lung cancer.
Chen N; Wu Q; Zhang G; Fu J; Geng Q; Zhang Y
Tissue Cell; 2022 Jun; 76():101750. PubMed ID: 35182988
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA CCT3 is a unique molecular marker in bladder cancer.
Luo L; Xie Q; Wu Y; Li P; Qin F; Liao D; Wang K
BMC Cancer; 2023 Oct; 23(1):977. PubMed ID: 37833621
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
Zhang MY; Lin J; Kui YC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
[TBL] [Abstract][Full Text] [Related]
13. ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition.
Li Y; Sun C; Tan Y; Zhang H; Li Y; Zou H
Int J Biol Sci; 2021; 17(2):635-650. PubMed ID: 33613118
[No Abstract] [Full Text] [Related]
14. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
[TBL] [Abstract][Full Text] [Related]
15. Suppression of CCT3 inhibits melanoma cell proliferation by downregulating CDK1 expression.
Liu W; Zhang X; Chen C; Li Y; Yang C; Han Z; Jiang G; Liu Y
J Cancer; 2022; 13(6):1958-1971. PubMed ID: 35399722
[TBL] [Abstract][Full Text] [Related]
16. Suppression of CCT3 Inhibits Tumor Progression by Impairing ATP Production and Cytoplasmic Translation in Lung Adenocarcinoma.
Chen S; Tian Y; Ju A; Li B; Fu Y; Luo Y
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409343
[TBL] [Abstract][Full Text] [Related]
17. Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells.
Zhang Y; Wang Y; Wei Y; Wu J; Zhang P; Shen S; Saiyin H; Wumaier R; Yang X; Wang C; Yu L
Cancer Lett; 2016 Mar; 372(1):101-9. PubMed ID: 26739059
[TBL] [Abstract][Full Text] [Related]
18. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD.
Yu M; Chen Y; Li X; Yang R; Zhang L; Huangfu L; Zheng N; Zhao X; Lv L; Hong Y; Liang H; Shan H
Cell Death Dis; 2018 May; 9(5):464. PubMed ID: 29700328
[TBL] [Abstract][Full Text] [Related]
19. Chaperonin containing TCP-1 subunit 3 is critical for gastric cancer growth.
Li LJ; Zhang LS; Han ZJ; He ZY; Chen H; Li YM
Oncotarget; 2017 Dec; 8(67):111470-111481. PubMed ID: 29340068
[TBL] [Abstract][Full Text] [Related]
20. CCT3 suppression prompts apoptotic machinery through oxidative stress and energy deprivation in breast and prostate cancers.
Temiz E; Koyuncu İ; Sahin E
Free Radic Biol Med; 2021 Mar; 165():88-99. PubMed ID: 33508424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
